This Part provides a basis for the creation of protected cells by a domestic insurer as one means of accessing alternative sources of capital and achieving the benefits of insurance securitization. Investors in fully funded insurance securitization transactions provide funds that are available to pay the insurer's insurance obligations or to repay the investors or both. The creation of protected cells is intended to be a means to achieve more efficiencies in conducting insurance securitizations. (2001-223, s. 25.)
Sections: Previous 58-10-30 58-10-35 58-10-40 58-10-45 58-10-55 58-10-60 58-10-65 58-10-75 58-10-80 58-10-85 58-10-90 58-10-95 58-10-100 58-10-105 58-10-110 Next
Last modified: March 23, 2014